why choose us

First received: June 01, 2023

Clinical Trial: A Study of Lazertinib (JNJ-73841937) Tablet in Healthy Adult Participants

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label, Randomized, 2-Part, 2-Way Crossover Study in Healthy Adult Participants to Assess the Relative Bioavailability of Tablet Formulations of Lazertinib (JNJ-73841937)

Brief Summary: The purpose of this study is to assess the extent of availability of drug to the body of four different lazertinib tablet formulations at a single oral dose under fasted conditions in healthy adult participants.

Read more